Krupal Ray

home / authors / krupal-ray

Krupal Ray is a PharmD candidate at the Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey.

Articles

GOLD Guidelines Provide Recommendations on Managing COPD

GOLD Guidelines Provide Recommendations on Managing COPD

Hamdi Lababidi, PharmD, MDc;Krupal Ray;Deepali Dixit, PharmD, BCPS, BCCCP, FCCM
November 16th 2022

Pivotal resource helps health care professionals diagnose, manage, and prevent this group of lung diseases.

Read More

Guidelines on Venous Thromboembolism Treatment Offer Key Resource

Guidelines on Venous Thromboembolism Treatment Offer Key Resource

Hamdi Lababidi, PharmD, MDc;Krupal Ray
October 5th 2022

The American College of Chest Physicians' update of its CHEST guidelines for the treatment of VTE includes 29 guidance statements.

Read More

Latest Updated Articles

AI patient pharmacist provider interactions ASHP summer
Published: June 11th 2024 | Updated: July 27th 2024
Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions
AI pharmacy futures AI disparities skin
Published: June 11th 2024 | Updated: July 27th 2024
Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications
Vice President Kamala Harris -- Image credit: Erin Schaff/Pool/AFP | GETTY | People.com
Published: July 23rd 2024 | Updated: July 27th 2024
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
Published: October 18th 2023 | Updated: July 27th 2024
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Small vial of influenza vaccine.
Published: July 23rd 2024 | Updated: July 27th 2024
Trivalent Influenza Vaccines Are Readied for Fall
Eye Care Pharmacy | Image Credit: I Viewfinder - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD